@article{4b1b4b0b5283490fba5425c595fdf0c0,
title = "Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics.",
abstract = "This is the second half of a two-part document updating the standard of care recommendations for spinal muscular atrophy published in 2007. This part includes updated recommendations on pulmonary management and acute care issues, and topics that have emerged in the last few years such as other organ involvement in the severe forms of spinal muscular atrophy and the role of medications. Ethical issues and the choice of palliative versus supportive care are also addressed. These recommendations are becoming increasingly relevant given recent clinical trials and the prospect that commercially available therapies will likely change the survival and natural history of this disease.",
keywords = "spinal muscular atrophy, spinal muscular atrophy",
author = "Finkel, {Richard S.} and Mercuri, {Eugenio Maria} and Meyer, {Oscar H.} and Simonds, {Anita K.} and Schroth, {Mary K.} and Graham, {Robert J.} and Janbernd Kirschner and Iannaccone, {Susan T.} and Crawford, {Thomas O.} and Simon Woods and Francesco Muntoni and Brunhilde Wirth and Jacqueline Montes and Marion Main and Mazzone, {Elena Stacy} and Michael Vitale and Brian Snyder and Susana Quijano-Roy and Enrico Bertini and Bertini, {Enrico Silvio} and Davis, {Rebecca Hurst} and Ying Qian and Thomas Sejersen",
year = "2018",
doi = "10.1016/j.nmd.2017.11.004",
language = "English",
pages = "197--207",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010",
}